ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,675, issued on Dec. 30, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).
"Aminoacyl-tRNA synthetases and uses hereof" was invented by Hongtao Guan (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to aminoacyl-tRNA synthetases that aminoacylate tRNA with 2-Aminoisobutyric acid (Aib), thus enabling the incorporation of the Aib into a growing polypeptide chain during translation, e.g. in eubacterial host cells such as E. coli. For example, but not limited to, the invention relates to new aminoacyl-tRNA synthetases and the uses hereof, as well as a method for producing polypeptides that contain one or more Aib."
The p...